Profile data is unavailable for this security.
About the company
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
- Revenue in USD (TTM)2.27m
- Net income in USD-89.93m
- Incorporated2020
- Employees159.00
- LocationQuantum-Si Inc29 Business Park DriveBRANFORD 06405United StatesUSA
- Phone+1 (203) 458-7100
- Fax+1 (302) 636-5454
- Websitehttps://www.quantum-si.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Instil Bio Inc | 0.00 | -75.17m | 161.04m | 49.00 | -- | 0.9163 | -- | -- | -11.56 | -11.56 | 0.00 | 27.02 | 0.00 | -- | -- | 0.00 | -24.53 | -- | -25.52 | -- | -- | -- | -- | -- | -- | -492.20 | 0.3179 | -- | -- | -- | 30.06 | -- | -- | -- |
| 2Seventy Bio Inc | 45.62m | -94.55m | 162.73m | 274.00 | -- | 0.7136 | -- | 3.57 | -1.85 | -1.85 | 0.8659 | 4.43 | 0.0797 | -- | 2.18 | 166,496.30 | -16.52 | -- | -18.31 | -- | 65.72 | 91.76 | -207.25 | -223.57 | -- | -- | 0.00 | -- | 9.72 | 12.96 | 14.39 | -- | -22.88 | -- |
| Adaptimmune Therapeutics PLC - ADR | 175.04m | -44.52m | 162.81m | 449.00 | -- | 2.04 | -- | 0.9301 | -0.2126 | -0.2126 | 0.7109 | 0.3128 | 0.5701 | -- | 26.34 | 389,846.30 | -14.50 | -41.19 | -18.73 | -48.21 | -- | -- | -25.43 | -714.26 | 3.82 | -- | 0.384 | -- | 122.05 | 0.2595 | 31.18 | -- | 0.7202 | -- |
| Galectin Therapeutics Inc | 0.00 | -45.23m | 169.40m | 14.00 | -- | -- | -- | -- | -0.7284 | -0.7284 | 0.00 | -1.48 | 0.00 | -- | -- | 0.00 | -176.31 | -92.08 | -587.13 | -121.97 | -- | -- | -- | -- | -- | -7.18 | 8.66 | -- | -- | -- | -15.26 | -- | -- | -- |
| Checkpoint Therapeutics Inc | 47.00k | -46.47m | 169.45m | 23.00 | -- | -- | -- | 3,605.29 | -1.44 | -1.44 | 0.0013 | -0.2749 | 0.0127 | -- | -- | 2,043.48 | -1,256.40 | -142.43 | -- | -342.79 | -- | -- | -98,868.09 | -6,554.97 | -- | -- | -- | -- | -46.35 | -50.61 | 17.21 | -- | -- | -- |
| Greenwich Lifesciences Inc | 0.00 | -10.50m | 170.49m | 3.00 | -- | 34.22 | -- | -- | -0.8111 | -0.8111 | 0.00 | 0.3791 | 0.00 | -- | -- | 0.00 | -140.17 | -36.43 | -151.72 | -38.31 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -13.63 | -- | -- | -- |
| Tenaya Therapeutics Inc | 0.00 | -117.23m | 171.12m | 140.00 | -- | 1.52 | -- | -- | -1.44 | -1.44 | 0.00 | 1.42 | 0.00 | -- | -- | 0.00 | -70.20 | -- | -78.56 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.3388 | -- | -- | -- |
| Kyverna Therapeutics Inc | 0.00 | -110.66m | 172.16m | 119.00 | -- | 0.569 | -- | -- | -2.50 | -2.50 | 0.00 | 7.01 | 0.00 | -- | -- | 0.00 | -51.27 | -- | -57.66 | -- | -- | -- | -- | -- | -- | -- | 0.0038 | -- | -100.00 | -- | -108.93 | -- | -- | -- |
| Nkarta Inc | 0.00 | -110.61m | 172.19m | 159.00 | -- | 0.3996 | -- | -- | -1.87 | -1.87 | 0.00 | 6.11 | 0.00 | -- | -- | 0.00 | -23.59 | -32.39 | -24.86 | -34.05 | -- | -- | -- | -372,519.20 | -- | -- | 0.00 | -- | -- | -- | -3.22 | -- | 106.05 | -- |
| Quantum-Si Inc | 2.27m | -89.93m | 172.26m | 159.00 | -- | 0.8203 | -- | 76.02 | -0.6334 | -0.6334 | 0.016 | 1.48 | 0.0082 | 0.3423 | 3.05 | 14,251.57 | -32.43 | -- | -34.05 | -- | 51.54 | -- | -3,968.84 | -- | 13.15 | -- | 0.00 | -- | -- | -- | 27.55 | -- | -- | -- |
| Inozyme Pharma Inc | 0.00 | -96.49m | 172.81m | 59.00 | -- | 2.09 | -- | -- | -1.55 | -1.55 | 0.00 | 1.29 | 0.00 | -- | -- | 0.00 | -55.29 | -45.00 | -60.60 | -48.90 | -- | -- | -- | -- | -- | -- | 0.3554 | -- | -- | -- | -6.13 | -- | 2.85 | -- |
| Verastem Inc | 10.00m | -93.45m | 174.91m | 73.00 | -- | 14.31 | -- | 17.49 | -3.18 | -3.18 | 0.3311 | 0.8002 | 0.0661 | -- | 100.00 | 136,986.30 | -61.78 | -62.70 | -77.44 | -75.18 | -- | -- | -934.54 | -406.17 | -- | -- | 0.5579 | -- | -100.00 | -- | -18.36 | -- | -- | -- |
| Actuate Therapeutics Inc | -100.00bn | -100.00bn | 175.78m | 11.00 | -- | 32.80 | -- | -- | -- | -- | -- | 0.2744 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0703 | -- | -- | -- | -22.74 | -- | -- | -- |
| DiaMedica Therapeutics Inc | 0.00 | -21.71m | 178.69m | 18.00 | -- | 3.73 | -- | -- | -0.5527 | -0.5527 | 0.00 | 1.12 | 0.00 | -- | -- | 0.00 | -39.23 | -45.38 | -41.66 | -48.24 | -- | -- | -- | -- | -- | -- | 0.0055 | -- | -- | -- | -41.72 | -- | -13.65 | -- |
| Caribou Biosciences Inc | 11.48m | -148.12m | 179.29m | 158.00 | -- | 0.6376 | -- | 15.62 | -1.65 | -1.65 | 0.128 | 3.11 | 0.0286 | -- | 5.08 | 72,626.59 | -36.94 | -- | -39.76 | -- | -- | -- | -1,290.81 | -- | -- | -1,321.46 | 0.00 | -- | 148.91 | -- | -2.66 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Quantum-Si Inc's reporting currency: US Dollar USD
36.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ARK Investment Management LLCas of 30 Sep 2024 | 11.84m | 9.67% |
| Nikko Asset Management Co., Ltd.as of 30 Sep 2024 | 7.55m | 6.17% |
| Nikko Asset Management Americas, Inc.as of 30 Sep 2024 | 7.53m | 6.15% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 6.32m | 5.17% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 4.96m | 4.05% |
| Geode Capital Management LLCas of 30 Sep 2024 | 2.32m | 1.89% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 2.27m | 1.85% |
| Jacobs Levy Equity Management, Inc.as of 30 Sep 2024 | 939.42k | 0.77% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2024 | 801.12k | 0.65% |
| Bridgeway Capital Management LLCas of 30 Sep 2024 | 406.70k | 0.33% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
